SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscalers Investor Day is driving attention, with management reaffirming its fiscal-year outlook and highlighting an ambitious long-term ARR goal and an AI-security collaboration with IBM and Red Hat; analysts responded with multiple price-target increases. Bulls are encouraged by the strategy and momentum, while skeptics question whether the long-term growth ambitions justify the valuation.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironments fiscal Q1 results beat expectations and showed a record funded backlog, reinforcing bullish interest in its drone and counter-drone businesses. The debate is whether those orders will translate into stronger growth and profitability: management maintained its full-year outlook, and some traders remain concerned about execution and the stocks muted, volatile reaction.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Oppenheimers upgrade to Outperform, citing rising contract values and early monetization of agentic-AI traffic, is driving attention to Fastly. Traders are cheering the rally and AI-growth thesis, while some dismiss the upgrade as hype and point to the stocks sharp swings.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is drawing attention after a steep selloff and repeated 52-week lows, with traders debating whether the decline reflects an expensive valuation, cost and growth concerns, competition, and weaker consumer spendingor an oversold pullback despite continued business growth. Bears expect more pressure, while bulls are buying the dip and arguing that the business remains sound; no single new catalyst dominates the discussion.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Iran-related attacks and disruption around the Strait of Hormuz are keeping tanker availability tight and freight rates elevated, driving attention to BWETs tanker-futures exposure. Traders are split between viewing persistent shipping risks as supportive and warning that the funds steep run-up leaves it vulnerable to a sharp reversal if tensions ease or traffic normalizes.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

Traders are discussing SQQQ as a hedge or bearish bet on a potential Nasdaq pullback, citing concerns about stretched tech and AI valuations, market highs, and macro risks. Others argue that Nasdaq strength and the ETFs daily leverage and decay make holding it risky, so the conversation is divided between anticipating a correction and warning against persistent losses.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrows recent quarterly revenue shortfall and concerns about meeting its full-year outlook are driving discussion, particularly doubts about VEVYEs pricing and whether prescription growth is translating into revenue. Traders are split between skepticism over managements forecasting and execution and the view that the setback is temporary, with growth from VEVYE, IHEEZO and the broader ophthalmology portfolio supporting the longer-term thesis.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms strong quarterly results and upbeat outlook, followed by a wave of analyst upgrades, are driving bullish interest. Traders are also debating the sharp post-earnings pullback, with profit-taking and concerns about higher rates, consumer credit, and valuation tempering optimism.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is rebounding after a sharp selloff triggered by CEO CJ Desais abrupt departure for Meta; traders calling the drop an overreaction point to former CEO Dev Ittycherias return as interim chief and positive Investor Day commentary, including raised guidance and a larger buyback authorization. Others remain cautious about leadership succession and valuation.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound has traders watching for a breakout, while bullish holders point to Chainlinks role in institutional tokenization and crypto infrastructure. Others see the move as a short-lived pump, note its correlation with broader crypto markets, and question whether network adoption will translate into value for the LINK token.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gland Pharma Secures USFDA Tentative Approval for Generic Lumify Eye Drops

Hyderabad: Gland Pharma Limited has announced that it … the United States. Gland Pharma , headquartered in Hyderabad, is a pharmaceutical company primarily focused … powders, infusions, oncology drugs , and ophthalmic solutions. Gland Pharma is also known …

Gland Pharma Names Dr Jitendra Gangwal Vice President, Research & Development

New Delhi: Gland Pharma has appointed Dr … institutions and leading Indian pharmaceutical companies. Over the course … . Prior to joining Gland Pharma , Dr. Gangwal was associated … . Reddy’s Laboratories, Glenmark Pharmaceuticals , Alkem Laboratories, and FDC …

Brief India: Aequitas: Aditya Infotech IPO Lockup Expiry- Has Continued Its Good Run, Dixon Tech Could Book Gains and more

In this briefing: Aequitas: Aditya Infotech IPO Lockup Expiry- Has Continued Its Good Run, Dixon Tech Could Book Gains LG Electronics India (Initiating Coverage): Steering Through Winds of Leadership and Innovation. ADD SBI Life Insurance Co Ltd - Strong Quarter; Business Momentum to Continue! Maruti Suzuki Ltd - Export Momentum Supports Growth; Domestic Competition Remains Intense Gland Pharma Ltd - Visible Turnaround in Cenexi with Strong Base 1. Aequitas: Aditya Infotech IPO Lockup Expiry- Has Continued Its Good Run, Dixon Tech Could Book Gains Aditya Infotech Ltd (6596564Z IN) (AIL) raised around US$151m in its IPO in August 2025. The lockup on its pre-IPO investors is set to expire soon. AIL is a CCTV/video surveillance provider company offering a range of advanced video security and surveillance products, technologies and solutions for enterprise and consumer segments under its CP PLUS brand. In this note, we will talk about the lockup dynamics and possible placement. 2. LG Electronics India (Initiating Coverage): Steering Through Winds of Leadership and Innovation.

Brief India: LG Electronics India (Initiating Coverage): Steering Through Winds of Leadership and Innovation. ADD and more

In this briefing: LG Electronics India (Initiating Coverage): Steering Through Winds of Leadership and Innovation. ADD SBI Life Insurance Co Ltd - Strong Quarter; Business Momentum to Continue! Maruti Suzuki Ltd - Export Momentum Supports Growth; Domestic Competition Remains Intense Gland Pharma Ltd - Visible Turnaround in Cenexi with Strong Base TVS Motor Co Ltd - Twin Growth Drivers: EV Expansion & Export Strength 1. LG Electronics India (Initiating Coverage): Steering Through Winds of Leadership and Innovation. ADD We initiate coverage on LG Electronics India (LG) with an ADD rating and a TP of INR 1,545 per share, valuing it at 38x Mar-28E AEPS We like LG for its market leadership in core product categories, strong brand equity, consistent technological innovations and product launches, healthy balance sheet, robust return ratios, and low working capital needs LG is a leading player in washing machines, refrigerators, panel televisions, and inverter ACs. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief India: Maruti Suzuki Ltd - Export Momentum Supports Growth; Domestic Competition Remains Intense and more

In this briefing: Maruti Suzuki Ltd - Export Momentum Supports Growth; Domestic Competition Remains Intense Gland Pharma Ltd - Visible Turnaround in Cenexi with Strong Base TVS Motor Co Ltd - Twin Growth Drivers: EV Expansion & Export Strength Primer: Jammu & Kashmir Bank (JKBK IN) - Jan 2026 Exencial Industry Tidings 1. Maruti Suzuki Ltd - Export Momentum Supports Growth; Domestic Competition Remains Intense Domestic Market Share & Profitability Outlook: Domestic demand witnessed a sharp inflection in Q3FY26 following the government’s landmark GST reduction, which catalysed industry growth to ~20.5% YoY versus a decline of ~0.4% in H1FY26. MSIL outperformed the industry with domestic volume growth of ~22%, supported by strong traction across small cars and SUVs. Management highlighted a revival in the small car segment, which transitioned from a “red zone” of negative growth to healthy expansion, aided by improved affordability and a 7% rise in first-time buyers, particularly upgrades from two-wheelers.

Gland Pharma Shares Surge Over 9%, Q3 FY26 Profit Rises 28% To ₹261 Crore

Gland Pharma shares surged over 9 percent after Q3 FY26 profit rose 28 percent and revenue grew 23 percent. Strong product launches, higher R&D spending, and heavy trading volumes boosted investor sentiment.The strong stock movement came after the Hyderabad-based drug maker announced its financial results for the third quarter of FY26 after market hours on Wednesday.

Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution

… Regulations, 2015, Gland Pharma stated that the USFDA approval … United States market. Gland Pharma , established in 1978 and … injectable and ophthalmic-focused pharmaceutical company with operations across … in India. Gland Pharma stated that the approval …

These two companies will sell shovels during India’s semaglutide gold rush

Shaily Engineering Plastics Ltd and Gland Pharma Ltd, involved in the making and filling of injectable pens for semaglutide, stand to win big as patients will need these devices irrespective of which brand of the drug they choose.

Brief India: PVR’s Two-Front War: Defending Premium SPH While Chasing Asset-Light Scale and more

In this briefing: PVR’s Two-Front War: Defending Premium SPH While Chasing Asset-Light Scale Gland Pharma Ltd - Poised for Stronger H2 Momentum; Rating Upgraded to BUY Westlife Foodworld Ltd - Resilience Amid Demand Softness; Maintain BUY Auto Monthly Sales Volume - October 2025 NOCIL Ltd - Pricing Pressure Continues; Global Uncertainties Adding to the Woes 1. PVR’s Two-Front War: Defending Premium SPH While Chasing Asset-Light Scale PVR Inox is piloting a full-service "dine-in" cinema concept in Bengaluru, while management confirms a major strategic shift towards an asset-light (FOCO) model for new screen expansion. The dine-in is a defensive move to protect premium Spend Per Head (SPH) against OTT, while the asset-light pivot is move to fix the balance sheet and scale in Tier-2/3. The company is re-engineering its business to be less dependent on its own capital, but its profitability remains entirely dependent on the one thing it cannot control: the content pipeline . 2. Gland Pharma Ltd - Poised for Stronger H2 Momentum; Rating Upgraded to BUY Stable Core and Cenexi Turnaround Drive Revenue Growth: Gland Pharma reported consolidated revenue of Rs 1,487 Cr in Q2FY26, marking a 5.8% YoY growth, in line with our estimates.

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

… and patented drugs entering … pharma space include the likes of Natco Pharma , Laurus Labs, Alembic Pharma , Sun Pharma … , Gland Pharma , Ajanta Pharma , and Glenmark Pharmaceuticals … of Indian pharmaceutical exports. …

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. The company was founded by P. V. N. Raju in 1978 and is headquartered in Sangareddy, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	16.64	--	--	N/A
Q1 '26	18.56	19.22	3.54%	BEAT
Q4 '25	18.72	--	--	N/A
Q3 '25	15.78	15.87	0.58%	BEAT
Q2 '25	13.07	11.20	-14.28%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

GLAND.NSE Earnings

Upcoming Earnings: Q2 '26

Historical Earnings